These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13097966)

  • 1. [Pathology of the prostate carcinoma].
    BIBUS B
    Krebsarzt; 1953 Jun; 8(5-6):144-9. PubMed ID: 13097966
    [No Abstract]   [Full Text] [Related]  

  • 2. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.
    Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA
    BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostate-specific antigen. A new marker of prostatic pathology].
    Boccon-Gibod L; Géraud M; Dugué MA
    Ann Urol (Paris); 1988; 22(3):206-10. PubMed ID: 2456714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prostatic fluid in prostatic pathology.
    Grayhack JT; Lee C
    Prog Clin Biol Res; 1981; 75A():231-46. PubMed ID: 6175976
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostate-specific antigen in prostatic pathology].
    Teillac P; Peyret C; Leroy M; Najean Y; Le Duc A
    Ann Urol (Paris); 1988; 22(3):193-6. PubMed ID: 2456712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances on molecular pathology of prostate carcinoma].
    Niu HL; Tao Y
    Ai Zheng; 2003 May; 22(5):552-6. PubMed ID: 12753724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
    Kim ED; Smith ND; Grayhack JT
    J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular metastases from carcinoma of the prostate.
    Escoffery CT; Shirley SE
    West Indian Med J; 1999 Dec; 48(4):235-7. PubMed ID: 10639848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malakoplakia associated with prostatic adenocarcinoma: Report of 4 cases and literature review.
    Medlicott S; Magi-Galluzzi C; Jimenez RE; Trpkov K
    Ann Diagn Pathol; 2016 Jun; 22():33-7. PubMed ID: 27180057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamentals on the pathology of prostatic carcinoma after brachytherapy.
    Helpap B
    World J Urol; 2002 Sep; 20(4):207-12. PubMed ID: 12215847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy.
    Langer JE; Rovner ES; Coleman BG; Yin D; Arger PH; Malkowicz SB; Nisenbaum HL; Rowling SE; Tomaszewski JE; Wein AJ; Jacobs JE
    J Urol; 1996 Jan; 155(1):228-31. PubMed ID: 7490841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens.
    Amin M; Boccon-Gibod L; Egevad L; Epstein JI; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R
    Scand J Urol Nephrol Suppl; 2005 May; (216):20-33. PubMed ID: 16019757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic tumors in Iran.
    Habibi A; Manouchehri A; Diba MH; Sajadi M; Ghavam M
    Int Surg; 1975 Aug; 60(8):405-7. PubMed ID: 1158617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rectal hemorrhage as the first manifestation of prostatic carcinoma].
    Asensio Lahoz LA; Abaitua Bilbao J; Palazuelos CM
    Arch Esp Urol; 1995; 48(6):640-1. PubMed ID: 7661643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural Pathology of the human prostatic gland. Cyto- and histormophogenesis of atrophy, hyperplasia, metaplasia, dysplasia and carcinoma (author's transl)].
    Kastendieck H
    Veroff Pathol; 1977; (106):1-163. PubMed ID: 73278
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma].
    Gualdi GF; Polettini E; Casciani E
    Clin Ter; 1996; 147(1-2):51-66. PubMed ID: 8767956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.